# A Pilot Study of Commercially Available Bowel Preparation Regimens Packaged and Ingested Via Vegan Capsules

> **NCT07700277** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Ottawa Hospital Research Institute** · enrollment: 80 (estimated)

## Conditions studied

- Lower Gastrointestinal Disorder
- Tolerance

## Interventions

- **DRUG:** Sodium picosulfate, magnesium oxide, and citric acid capsules
- **DRUG:** Polyethylene glycol 3350 with electrolytes capsules

## Key facts

- **NCT ID:** NCT07700277
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2027-08-01
- **Final completion:** 2027-12-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07700277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07700277, "A Pilot Study of Commercially Available Bowel Preparation Regimens Packaged and Ingested Via Vegan Capsules". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07700277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*